System Raises $20M in Funding

System, based in San Francisco, is a vertically integrated peptide platform that connects patients with licensed clinicians and pharmacy-grade compound treatments. The company announced it has raised $20 million in new funding to scale its infrastructure and expand access to regulated peptide therapies.

Investors

Patron Fund, Will Ventures, Vine, Courtside, Daybreak, SV Angel, and RiverPark Ventures participated in the round.

System Use of Funds

System plans to use the capital to accelerate its mission of becoming a trusted, peptide-native platform and to continue building out its supply chain infrastructure as the peptide market transitions into a more regulated era.

About System

Founded by CEO Adam Steinle, System provides a vertically integrated healthcare platform that pairs patients with U.S.-licensed clinicians for the prescription of personalized peptide protocols. The company sources its treatments from certified American compounding pharmacies, aiming to provide a transparent and accessible alternative to traditional concierge medicine.

Funding Details

Company Website: https://systemlabs.com

Company: System
Raised: $20M
Funding Date: September 9, 2026
Additional Investors: Patron Fund, Will Ventures, Vine, Courtside, Daybreak, SV Angel, RiverPark Ventures
Company Website: https://systemlabs.com
Software Category: Healthtech
Source: https://www.prnewswire.com/news-releases/system-raises-20m-in-funding-to-become-the-trusted-peptide-native-platform-for-a-new-era-302873360.html